Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inex Pharmaceuticals Corp.

Division of Arbutus Biopharma Corp.

Latest From Inex Pharmaceuticals Corp.

Talon’s Marqibo Faces Commercial Challenges After FDA Approval

Talon is preparing to launch the leukemia drug on its own in the first quarter of 2013 but remains in talks with potential strategic partners. The company agreed to monitor whether clinical practices experience safety or technical problems while following the 26-step process for preparing the drug for administration.

BioPharmaceutical United States

Talon Marqibo’s Confirmatory Trial Plan May Need To Be Reworked

FDA advisory committee members express concern about the toxicity of Marqibo in the elderly patients expected to enroll in the Phase III confirmatory study for advanced acute lymphoblastic leukemia.

BioPharmaceutical United States

Talon Marqibo’s Fate May Hang On Adjudication Of Trial Subjects

With Talon offering a single Phase II trial to support its NDA for Marqibo (vincristine sulfate liposomal injection) for relapsed Philadelphia chromosome negative acute lymphoblastic leukemia, everything may hinge on the disagreement between the sponsor and FDA over whether eight patients or 13 out of 65 experienced some type of complete response.

BioPharmaceutical United States

RNAi Creates Novel Court Filings; Tekmira In Trade Secrets Dispute With AlCana

A British Columbia court orders AlCana to return thousands of documents it allegedly downloaded from Tekmira’s electronic document management system. The claim arose from Tekmira’s suit against Alnylam and AlCana alleging trade secrets theft.

BioPharmaceutical Legal Issues
See All

Company Information

  • Industry
  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule
    • Liposomes
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Parent & Subsidiaries
  • Arbutus Biopharma Corp.
  • Senior Management
  • David J Main, Pres. & CEO
    Jeff Charpentier, VP, Fin. & CFO
    Pieter R Cullis, PhD, SVP, Research & CSO
  • Contact Info
  • Inex Pharmaceuticals Corp.
    ,
Advertisement
Advertisement
UsernamePublicRestriction

Register